Skip to main content
. 2018 Mar 11;10(1):32. doi: 10.3390/pharmaceutics10010032

Figure 4.

Figure 4

Fluorescence intensity analysis of free DOX and DOX-loaded CA and CMCA NPs. (A) drug binding efficiency (%) of CA, CMCA and SMCA NPs for 5 µM DOX; (B) drug binding efficiency (%) of CA, CMCA and SMCA NPs for 10 µM DOX.